Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
IDENIX PHARMACEUTICALS INC
| Metric | IDENIX PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 22 / 100 |
| Revenue (latest) | $852,000 |
| Net income (latest) | −$31M |
| Operating margin | −14521.1% |
| Net margin | −3609.5% |
| Return on equity | −29.0% |
| Return on assets | −21.8% |
| Return on capital (ROCE) | −100.7% |
| Debt / equity | 0.33× |
| Revenue growth (YoY) | −97.6% |
| Altman Z″ (distress) | -16.73 |
| Accruals / assets | 55.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.